- Home
- BNZI vs CRIS Comparison
BNZI vs CRIS Comparison
Compare BNZI & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- CRIS
- Stock Information
- Founded
- BNZI 2016
- CRIS 2000
- Country
- BNZI United States
- CRIS United States
- Employees
- BNZI N/A
- CRIS N/A
- Industry
- BNZI
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BNZI
- CRIS Health Care
- Exchange
- BNZI Nasdaq
- CRIS Nasdaq
- Market Cap
- BNZI 16.4M
- CRIS 13.5M
- IPO Year
- BNZI N/A
- CRIS 2000
- Fundamental
- Price
- BNZI $1.01
- CRIS $1.96
- Analyst Decision
- BNZI Strong Buy
- CRIS Strong Buy
- Analyst Count
- BNZI 1
- CRIS 3
- Target Price
- BNZI $26.00
- CRIS $21.00
- AVG Volume (30 Days)
- BNZI 816.7K
- CRIS 106.4K
- Earning Date
- BNZI 05-15-2025
- CRIS 05-06-2025
- Dividend Yield
- BNZI N/A
- CRIS N/A
- EPS Growth
- BNZI N/A
- CRIS N/A
- EPS
- BNZI N/A
- CRIS N/A
- Revenue
- BNZI $4,527,879.00
- CRIS $11,202,000.00
- Revenue This Year
- BNZI $430.54
- CRIS $2.62
- Revenue Next Year
- BNZI N/A
- CRIS $9.84
- P/E Ratio
- BNZI N/A
- CRIS N/A
- Revenue Growth
- BNZI N/A
- CRIS 14.17
- 52 Week Low
- BNZI $0.74
- CRIS $1.02
- 52 Week High
- BNZI $19.75
- CRIS $16.93
- Technical
- Relative Strength Index (RSI)
- BNZI 46.38
- CRIS 52.24
- Support Level
- BNZI $0.98
- CRIS $1.06
- Resistance Level
- BNZI $1.07
- CRIS $2.45
- Average True Range (ATR)
- BNZI 0.06
- CRIS 0.30
- MACD
- BNZI 0.00
- CRIS 0.02
- Stochastic Oscillator
- BNZI 19.44
- CRIS 36.19
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.